1. Home
  2. NTWK vs CVM Comparison

NTWK vs CVM Comparison

Compare NTWK & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NetSol Technologies Inc.

NTWK

NetSol Technologies Inc.

N/A

Current Price

$3.59

Market Cap

39.7M

Sector

Technology

ML Signal

N/A

Logo Cel-Sci Corporation

CVM

Cel-Sci Corporation

HOLD

Current Price

$3.56

Market Cap

32.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTWK
CVM
Founded
1997
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.7M
32.4M
IPO Year
1997
1996

Fundamental Metrics

Financial Performance
Metric
NTWK
CVM
Price
$3.59
$3.56
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
32.7K
39.4K
Earning Date
05-22-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
316.67
N/A
EPS
N/A
N/A
Revenue
$73,088,687.00
$264,033.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
13.40
65.45
52 Week Low
$2.14
$0.18
52 Week High
$5.75
$13.48

Technical Indicators

Market Signals
Indicator
NTWK
CVM
Relative Strength Index (RSI) 54.15 34.46
Support Level $2.87 $3.34
Resistance Level $3.67 $6.82
Average True Range (ATR) 0.15 0.35
MACD 0.01 -0.03
Stochastic Oscillator 64.04 14.60

Price Performance

Historical Comparison
NTWK
CVM

About NTWK NetSol Technologies Inc.

NETSOL Technologies Inc is an information technology and enterprise software solutions provider to original equipment manufacturers (OEMs), dealerships, and financial institutions to sell, finance, and lease assets. The firm's products include Transcend Retail, Transcend Finance, Transcend Marketplace, Transcend Consultancy, and Transcend AI Labs, catering to its customers in the different stages of how assets are sold, financed, and leased. Its primary sources of revenue are licensing, subscriptions, modification, enhancement, and support of its suite of financial applications offered to businesses in the finance and leasing space, as well as automotive digital retail. The company has three reportable segments: Asia-Pacific, its key revenue-generating market, North America, and Europe.

About CVM Cel-Sci Corporation

CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.

Share on Social Networks: